Updated: February 14, 2026
76 people read this article
Dificid Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Is Dificid in shortage in 2026? Get the latest update on Dificid (Fidaxomicin) availability, cost, generic options, and what patients can do right now.
Dificid Shortage Update: What Patients Need to Know in 2026
If you've been told your pharmacy can't get Dificid (Fidaxomicin), you might be wondering: is there a Dificid shortage? The answer is a little more nuanced than a simple yes or no.
In this article, we'll give you the latest information on Dificid availability in 2026, explain why it's been hard to find, break down what it costs now, and share what you can do to get your prescription filled.
Is Dificid Still in Shortage?
As of early 2026, Dificid is not officially listed on the FDA's drug shortage database. That means there isn't a manufacturing or supply chain shortage in the traditional sense.
However, many patients still report difficulty finding Dificid at their local pharmacy. The reason isn't a shortage of the drug itself — it's a stocking and access problem. Many pharmacies simply don't carry it because of the extreme cost and relatively low prescription volume compared to common medications.
The situation improved significantly in July 2025 when Teva launched the first generic version of Fidaxomicin. The generic is more affordable, making pharmacies more willing to stock it. But the transition is still ongoing, and availability varies by location.
Why Is Dificid Hard to Find?
Several factors make Dificid challenging to locate:
High Cost
Brand-name Dificid costs between $5,100 and $6,550 for a single 10-day course (20 tablets). Even with the generic now available at approximately $1,290 to $1,800 with coupons, it remains one of the more expensive antibiotics on the market. Many retail pharmacies don't want to tie up thousands of dollars in inventory for a medication they may only dispense a few times per month.
Prior Authorization Requirements
Most insurance plans require prior authorization before covering Dificid. Many also require step therapy — your doctor must show that you've tried oral Vancomycin first (or explain why it's not appropriate). These requirements add delays and uncertainty, which discourages pharmacies from stocking the drug speculatively.
Increased Demand
The 2021 IDSA/SHEA guideline update elevated Fidaxomicin to first-line treatment for C. diff infections alongside Vancomycin. This increased prescription volume, but pharmacy stocking hasn't fully caught up.
Specialty Pharmacy Requirements
Some insurance plans require Dificid to be dispensed through a specialty pharmacy rather than a regular retail pharmacy. If you're at the wrong type of pharmacy for your plan, you'll be turned away even if the drug is technically available there.
For a deeper look at these challenges, read our article: Why Is Dificid So Hard to Find?
How Much Does Dificid Cost in 2026?
Here's a breakdown of current pricing:
- Brand-name Dificid: $5,100–$6,550 retail price for 20 tablets (10-day course)
- Generic Fidaxomicin (Teva): ~$1,290–$1,800 with discount coupons (GoodRx, SingleCare)
- With Merck Savings Coupon: As low as $50 per prescription for eligible commercially insured patients
- With Teva Copay Card: As low as $50 per prescription
- With insurance: Copays vary widely, from $50 to $500+ depending on your plan and formulary tier
For a complete breakdown of ways to save, read our guide to saving money on Dificid.
New Options in 2026
Generic Fidaxomicin
The biggest development is the Teva generic Fidaxomicin, launched in July 2025. This AB-rated generic is therapeutically equivalent to brand-name Dificid and is substantially cheaper. As more pharmacies adopt the generic, availability should continue to improve throughout 2026.
Microbiome-Based Therapies
For patients with recurrent C. diff, newer treatments like Vowst (oral fecal microbiota spores) and Rebyota (rectally administered fecal microbiota) are becoming more established. These aren't replacements for Dificid — they're used after antibiotic treatment to restore gut bacteria and prevent recurrence. Learn about all options in our alternatives guide.
How to Find Dificid in Stock Right Now
Here's a step-by-step plan:
- Search on Medfinder to find pharmacies near you that have Dificid or generic Fidaxomicin in stock right now
- Ask for the generic — Teva's Fidaxomicin is more widely stocked and cheaper
- Try independent pharmacies — they're often more flexible about special-ordering medications
- Contact your prescriber's office — they can help expedite prior authorization and may know which pharmacies stock it
- Check hospital outpatient pharmacies — especially if you were recently hospitalized for C. diff
- Ask about specialty pharmacy options — if your insurance requires one, get the process started right away
For detailed strategies, see our full guide: How to Find Dificid in Stock Near You.
Final Thoughts
While Dificid isn't in a formal FDA-listed shortage, real-world availability remains a challenge for many patients in 2026. The good news is that the generic launch in 2025 is steadily improving the landscape, and there are more tools and options available than ever before.
If you're struggling to find Dificid, don't wait — C. diff infections need prompt treatment. Use Medfinder to check real-time pharmacy availability, explore savings programs to reduce costs, and keep your doctor informed so they can help you get the treatment you need.
Frequently Asked Questions
No, Dificid is not currently listed on the FDA's official drug shortage database. However, many patients have difficulty finding it at local pharmacies because of its high cost and limited stocking. The situation is improving since generic Fidaxomicin became available in July 2025.
Brand-name Dificid costs approximately $5,100 to $6,550 for a 10-day course (20 tablets). Generic Fidaxomicin (by Teva) costs approximately $1,290 to $1,800 with discount coupons from GoodRx or SingleCare. Manufacturer savings cards from both Merck and Teva can reduce the cost to as low as $50 for eligible commercially insured patients.
Teva launched generic Fidaxomicin tablets in July 2025. This was the first generic version of Dificid to reach the U.S. market. The generic is AB-rated, meaning the FDA considers it therapeutically equivalent to brand-name Dificid.
Search for nearby pharmacy availability on Medfinder at medfinder.com. If no pharmacies have it, contact your doctor immediately — they can help with prior authorization, suggest alternative treatments like oral Vancomycin, or arrange dispensing through a hospital pharmacy. For C. diff, timely treatment is critical, so don't delay in reaching out.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Dificid also looked for:
More about Dificid
28,922 have already found their meds with Medfinder.
Start your search today.
![Why Is Dificid So Hard to Find? [Explained for 2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F56f1ede91dc0ceca0a5a5ec5bec6180811e36a20-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)




